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Abstract 
Enhanced generation of reactive oxygen/ nitrogen species (ROS/RNS) and the ensuing phenomenon in the form of oxidative 
stress have been implicated in the etiology of cancer. Anti oxidants due to their ability to neutralize the toxic free radicals or 
damage induced by them have potential applications in the prevention and/or therapy of human ailments. Plumbagin, a 
napthaquinone derivative from Plumbago zeylanica and has been claimed to possess antitumor effect. Elevated levels of lipid 
peroxides and decreased activities of antioxidant enzymes such as catalase, superoxide dismutase and Glutathione 
peroxidase were assayed in plasma, liver and kidney of fibrosarcoma induced rats, and the levels significantly reverted back to 
normal, after treatment with plumbagin. These observations clearly suggested the antitumor potency of plumbagin in 
experimentally induced fibrosarcoma in rats. 
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Introduction 
Fibrosarcoma is a malignant neoplasm (cancer) of 
mesenchymal cell origin in which histologically the 
predominant cells are fibroblasts that divide 
excessively without cellular control; they can invade 
local tissues and travel to distant body sites. 
Fibrosarcoma is part of a larger collection of cancers 
known as sarcomas. Sarcomas are spindle cell 
malignancies of mesenchymal cell origin and are 
named and classified after the predominant cell line 
that is present. For example, in bone (osteosarcoma), 
cartilage (chondrosarcoma), smooth muscle 
(leiomyosarcoma), and skeletal muscle 
(rhabdomyosarcoma). Though all are sarcomas, 
specific diseases vary considerably in presentation, 
treatment, and prognosis. At the same time, there are 
characteristics shared by many sarcomas. Since, all 
are connective tissue in origin, they form solid tumors, 
as opposed to a disease such as leukemia in which 
abnormal cells are circulating in the blood stream, or 
certain gastrointestinal tract cancers that may develop 
within the wall of a hollow organ1. 
An ever increasing number of pharmacological 
effects have become known through the discovery of 
new herbal drugs with variations in chemical structure 
and related derivatives. Most of the herbal drugs are a 
mixture of a number of plant ingredients. So far, many 
products have been found to be active antitumor 
agents both in animal and human tumor2.  
Plumbagin, a napthaquinone derivative from 
Plumbago zeylanica were reported to have antitumor 
activity on rat fibrosarcoma. A prime goal of 
experiments with animal models is to further 
understanding of diseases of man and ultimately to 
provide information which can serve as a basis for their 
prevention and treatment. Hence, this study is 
designed to assess the antioxidant status of 
fibrosarcoma and also to understand the antitumor 
effects of plumbagin. 
Materials and Methods 
Plumbagin was purchased from Sigma (St. 
Louis,MO). Stock solution of plumbagin was made in 
dimethyl sulphoxide (DMSO) (Sigma). All other 
chemicals used were of analytical grade.Male Wistar 
rats weighing approximately 250g were housed in 
solid-bottomed polypropylene cages under strict 
veterinary supervision and maintained in control rooms 
with 12 h light/dark cycle. The animals received 
commercial rat diet and water ad libitum. This study 
confirmed to the guiding principles of Institutional 
Animal Ethical Committee (IAEC), Committee for the 
Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA) and the Guide for the Care and 
Use of Laboratory Animals. 
Experimental design and treatment protocol 
Induction of experimental fibrosarcoma  
Fibrosarcoma was induced in rats by the method 
of Jayamathi et al3. A suitable bit of the tumor was 
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minced into fine fragments suspended in physiological 
saline. A 10 % suspension (0.5 ml) of tumor tissue was 
injected into the auxiliary and inguinal regions through 
the usual puncture technique. The transplanted tumor 
takes a week to become palpable, grew up to the end 
of a week. The animals were broadly divided into two 
groups: 
Group 1: Control (received saline only); Group 2: 
Induced experimental fibrosarcoma. Animals of group 2 
were further divided into experimental fibrosarcoma at 
the 20th day and 30th day. 
Group 3: Experimental fibrosarcoma at the 20th 
day and 30th day + plumbagin (Plumbagin, was 
dissolved in 0.9% saline was injected subcutaneously 
(10mg/kg bodyweight). Each group comprised 6 
animals. After the experimental period, the animals 
were sacrificed by cervical decapitation and blood was 
collected for the biochemical investigations. The 
organs were blotted and cut them into pieces before 
weighing. 100mg of the tissue was weighed and 
homogenized in 0.1 M Tris HCl buffer (pH 7.4). The 
tissue homogenates were centrifuged and the 
supernatant was taken for assays. 
 
 
Biochemical assays 
Lipid peroxide4, anti oxidant enzymes such as 
catalase5, superoxide dismutase6 glutathione 
peroxidase7 were assayed in serum, liver and kidney 
tissues. Protein in serum was estimated by the method 
of Lowry et al.8, using crystalline bovine serum albumin 
as the reference standard. 
Statistical methods 
All values used in analysis represented as mean ± 
SE of 6 rats 
Results and Discussion 
The rate of formation of malondialdehyde (MDA), 
the end product of enhanced peroxidation of 
arachidonic acid (lipid peroxidation) and the levels 
were increased in fibrosarcoma bearing rats when it is 
compared with respective controls. The increase in 
malondialdehyde levels might be associated with the 
higher production of ROS.  It is well known that lipid 
oxidation and ROS are implicated in carcinogenesis 
and might be etiologically involved in the promotional 
phase9. In plumagin treated animals, the corrected 
level of these parameters were observed likely to near 
normal values showed significant protective effect 
(Table-1). 
 
Table 1. Levels of lipid peroxide in serum, liver and kidney of normal, fibrosarcoma induced rats and fibrosarcoma induced                                  
rats treated with plumagin 
 
 
 
 
 
 
 
 
Control 
Fibrosarcoma induced rats Fibrosarcoma induced rats treated 
with plumagin 
20th  day 30th  day 20th  day 30th  day 
Lipid  
peroxide 
Serum 2.32 ± 0.32 2.43 ± 0.36 2. 52 ± 0.4 2.40 ± 0.28 2.48 ± 0.28 
Liver 138.2 ± 11.7 159 ±  10.5 198 ± 9.5 152 ± 8.32 179.5 ± 8.17 
Kidney 75 ± 4.6 90.6 ± 3.5 115.2 ± 4.0 85.2 ±2.8 94.7 ± 3.2 
Lipid peroxide in serum  is expressed as n mol of malonyldialdehyde /ml;  in liver and kidney as n moles of malonyldialdehyde / 
100 mg protein .The values are expressed as mean ± SD (N = 6).  
 
Table 2. Activity of catalase, Super oxide dismutase, Glutathione peroxidase (GPx), and in liver and kidney of normal, fibrosarcoma induced 
rats and fibrosarcoma induced rats treated with plumagin 
 
  
 
 
Control 
Fibrosarcoma induced rats Fibrosarcoma induced rats treated with plumagin 
20th  day 30th  day 20th  day 30th  day 
 
Catalase 
Liver 67.5 ± 5.1 58.6 ±  4.8 55.5 ± 3.2 59.5 ± 5 60.5 ± 3.2 
Kidney 7.01 ± 0.62 5.25 ± 0.12 3.6 ± 0.2 5.65 ±0.3 5.8 ± 0.5 
Super oxide 
dismutase 
Liver 6.42 ± 0.7 4.95 ±  0.5 3.5 ± 0.6 5.15 ± 0.4 5.34 ± 0.5 
Kidney 3.18 ± 0.2 2.4 ± 0.1 1.75 ± 0.15 2.48 ±0.3 2.59 ± 0.1 
 
 GPx 
Liver 86.2 ± 5.4 74.2 ±  2.8 61.3  ± 2.5 76.5  ±  3.0 72.1 ± 2. 0 
Kidney 43.3 ± 4.7 34.3 ±  3.0 28.7 ± 2.7 36.1 ± 2.0 36.5 ± 2.1 
Catalase (CAT), Super oxide dismutase (SOD) and in liver and kidney as n moles of malonyldialdehyde / 100 mg protein.  One unit of SOD 
activity is the amount of protein required to give 50% inhibition of adrenaline autooxidation. CAT activity is expressed as n mol of hydrogen 
peroxide decomposed / min / mg protein. GPx as n moles of glutathione oxidized/ min/mg protein of normal, fibrosarcoma induced rats and 
fibrosarcoma induced rats treated with plumagin.  The values are expressed as mean ± SD (N = 6). 
 
Antioxidants are substances that prevent damage 
to cells caused by free radicals. Free radicals are 
molecules that have lost an electron, thus are unstable. 
These free radicals basically steal electrons from other 
molecules in effort to heal themselves, ultimately 
creating new free radicals in the process. By stealing 
electrons, it can cause damage to DNA, leading to the 
possible development of cancer10. The antioxidant 
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mechanisms are the evolutionary designs that avidly 
react and annihilate ROS before they inflict oxidative 
damage to tissues and cells ROS can cause DNA and 
protein damage, initiate lipid peroxidation, oxidize α1- 
antitrypsin and stimulate the release of 
proinflammatory cytokines11.  
Enzymatic antioxidants such as catalase, SOD 
and GPx in serum liver and kidney were decreased 
significantly in fibrosarcoma induced rats whereas 
plumagin treated groups were found to have significant 
protective effect as reflected by an increase in the 
levels of antioxidants as shown in Table 2. In plumagin 
treated animals, the corrected level of these 
parameters were observed likely to near normal values. 
Level of lipid peroxide was observed with concomitant 
decreases in the level of enzymatic antioxidants in 
fibrosarcoma bearing rats when compared with control 
animals.  
The present findings demonstrated that the 
reduced activities of catalase, SOD and GPx, were well 
correlated with an increase in MDA in fibrosarcoma 
bearing rats with respective controls, which are the 
products of enhanced peroxidation of arachidonic 
acid12. These observations clearly suggested the 
antitumor potency of plumagin in experimentally 
induced fibrosarcoma in rats. Therefore, attention has 
been focused on studying the various plant ingredients 
in the drug as a whole for its antitumor effects. 
 
Conclusion 
Thus, plumagin can be accepted to pose 
antioxidant mechanism against excessively formed 
reactive species due to impaired antioxidant systems in 
fibrosarcoma conditions that cause membrane damage 
leading to deleterious effects.  
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